Home

Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 05/12

Trade details

Type
Insider sale
Amount
$1,151,253.99
Shares · price
2,019 sh · $570.21 a share
Held after
46,829 sh
Trade date
26/05/11
Filed
26/05/12
Days to filing
1 days

Sold 4.1% of holdings

Share of holding sold
4.1%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 04/11~06/10

Martine A. Rothblatt's recent trades

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $775.2K

    Filed 10/02

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $537.5K

    Filed 10/02

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $501.3K

    Filed 10/02

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $477.2K

    Filed 10/02

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $446.5K

    Filed 10/02

Martine A. Rothblatt, Chairman — sold $1.2M of United Therapeutics UTHR · 4.1% of holdings · 10b5-1 plan | Whalegun